A Novel ENU-Induced Mfn2 Mutation Causes Motor Deficits in Mice without Causing Peripheral Neuropathy
Open Access
Abstract
Mitochondrial fission and fusion are required for maintaining functional mitochondria. The mitofusins (MFN1 and MFN2) are known for their roles in mediating mitochondrial fusion. Recently, MFN2 has been implicated in other important cellular functions, such as mitophagy, mitochondrial motility, and coordinating endoplasmic reticulum-mitochondria communication. In humans, over 100 MFN2 mutations are associated with a form of inherited peripheral neuropathy, Charcot–Marie–Tooth disease type 2A (CMT2A). Here we describe an ENU-induced mutant mouse line with a recessive neuromuscular phenotype. Behavioral screening showed progressive weight loss and rapid deterioration of motor function beginning at 8 weeks. Mapping and sequencing revealed a missense mutation in exon 18 of Mfn2 (T1928C; Leu643Pro), within the transmembrane domain. Compared to wild-type and heterozygous littermates, Mfn2L643P/L643P mice exhibited diminished rotarod performance and decreases in activity in the open field test, muscular endurance, mean mitochondrial diameter, sensory tests, mitochondrial DNA content, and MFN2 protein levels. However, tests of peripheral nerve physiology and histology were largely normal. Mutant leg bones had reduced cortical bone thickness and bone area fraction. Together, our data indicate that Mfn2L643P causes a recessive motor phenotype with mild bone and mitochondrial defects in mice. Lack of apparent nerve pathology notwithstanding, this is the first reported mouse model with a mutation in the transmembrane domain of the protein, which may be valuable for researchers studying MFN2 biology.Keywords
Funding Information
- Novartis (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
- 2021 Uplifting Athletes Young Investigator Draft and the Charcot-Marie-Tooth Association (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
- National Institutes of Health (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
- MHIR (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
- Genomics Institute of the Novartis Research Foundation (GNF) (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
- National Institutes of Health (NIH) (SFP-1406, P20GM121301, R37 NS054154, R24 NS098523)
This publication has 59 references indexed in Scilit:
- Mitofusin2 Mutations Disrupt Axonal Mitochondrial Positioning and Promote Axon DegenerationJournal of Neuroscience, 2012
- MFN2 mutations cause severe phenotypes in most patients with CMT2ANeurology, 2011
- Mitochondrial fusion and fission in cell life and deathNature Reviews Molecular Cell Biology, 2010
- Guidelines for assessment of bone microstructure in rodents using micro–computed tomographyJournal of Bone and Mineral Research, 2010
- Expression of mitofusin 2R94Q in a transgenic mouse leads to Charcot–Marie–Tooth neuropathy type 2ABrain, 2010
- Mitofusin 2 Is Necessary for Transport of Axonal Mitochondria and Interacts with the Miro/Milton ComplexThe Journal of Neuroscience, 2010
- Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusionJournal of Cell Biology, 2009
- Mitofusin 2 tethers endoplasmic reticulum to mitochondriaNature, 2008
- Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutationsJournal of Cell Biology, 2007
- Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial MetabolismJournal of Biological Chemistry, 2003